196 related articles for article (PubMed ID: 22382681)
1. Doxorubicin induces the persistent activation of intracellular transglutaminase 2 that protects from cell death.
Cho SY; Jeong EM; Lee JH; Kim HJ; Lim J; Kim CW; Shin DM; Jeon JH; Choi K; Kim IG
Mol Cells; 2012 Mar; 33(3):235-41. PubMed ID: 22382681
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes.
Salter NW; Ande SR; Nguyen HK; Nyomba BL; Mishra S
J Mol Endocrinol; 2012 Jun; 48(3):203-16. PubMed ID: 22394545
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG
Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207
[TBL] [Abstract][Full Text] [Related]
4. Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.
Carbone C; Di Gennaro E; Piro G; Milone MR; Pucci B; Caraglia M; Budillon A
Amino Acids; 2017 Mar; 49(3):517-528. PubMed ID: 27761756
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling.
Filiano AJ; Bailey CD; Tucholski J; Gundemir S; Johnson GV
FASEB J; 2008 Aug; 22(8):2662-75. PubMed ID: 18375543
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN.
Wang Y; Ande SR; Mishra S
BMC Cancer; 2012 Jul; 12():277. PubMed ID: 22759359
[TBL] [Abstract][Full Text] [Related]
7. Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer.
Lee J; Yakubov B; Ivan C; Jones DR; Caperell-Grant A; Fishel M; Cardenas H; Matei D
Neoplasia; 2016 Nov; 18(11):689-698. PubMed ID: 27792935
[TBL] [Abstract][Full Text] [Related]
8. Role of transglutaminase 2 in A
Vyas FS; Nelson CP; Dickenson JM
Eur J Pharmacol; 2018 Jan; 819():144-160. PubMed ID: 29208472
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.
Fisher ML; Keillor JW; Xu W; Eckert RL; Kerr C
Mol Cancer Res; 2015 Jul; 13(7):1083-94. PubMed ID: 25934691
[TBL] [Abstract][Full Text] [Related]
10. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
Kotsakis P; Wang Z; Collighan RJ; Griffin M
Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
[TBL] [Abstract][Full Text] [Related]
11. Gα(h)/transglutaminase-2 activity is required for maximal activation of adenylylcyclase 8 in human and rat glioma cells.
Obara Y; Yanagihata Y; Abe T; Dafik L; Ishii K; Nakahata N
Cell Signal; 2013 Mar; 25(3):589-97. PubMed ID: 23200849
[TBL] [Abstract][Full Text] [Related]
12. Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target.
Agnihotri N; Mehta K
Amino Acids; 2017 Mar; 49(3):425-439. PubMed ID: 27562794
[TBL] [Abstract][Full Text] [Related]
13. The complex role of transglutaminase 2 in glioblastoma proliferation.
Gundemir S; Monteagudo A; Akbar A; Keillor JW; Johnson GVW
Neuro Oncol; 2017 Feb; 19(2):208-218. PubMed ID: 27591334
[TBL] [Abstract][Full Text] [Related]
14. Glycolysis regulated transglutaminase 2 activation in cardiopulmonary fibrogenic remodeling.
Bhedi CD; Nasirova S; Toksoz D; Warburton RR; Morine KJ; Kapur NK; Galper JB; Preston IR; Hill NS; Fanburg BL; Penumatsa KC
FASEB J; 2020 Jan; 34(1):930-944. PubMed ID: 31914588
[TBL] [Abstract][Full Text] [Related]
15. Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization.
Gundemir S; Colak G; Feola J; Blouin R; Johnson GV
Biochim Biophys Acta; 2013 Jan; 1833(1):1-10. PubMed ID: 23085038
[TBL] [Abstract][Full Text] [Related]
16. Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis.
Liu T; Tee AE; Porro A; Smith SA; Dwarte T; Liu PY; Iraci N; Sekyere E; Haber M; Norris MD; Diolaiti D; Della Valle G; Perini G; Marshall GM
Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18682-7. PubMed ID: 18003922
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2 promotes both caspase-dependent and caspase-independent apoptotic cell death via the calpain/Bax protein signaling pathway.
Yoo JO; Lim YC; Kim YM; Ha KS
J Biol Chem; 2012 Apr; 287(18):14377-88. PubMed ID: 22418443
[TBL] [Abstract][Full Text] [Related]
18. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.
Sarang Z; Molnár P; Németh T; Gomba S; Kardon T; Melino G; Cotecchia S; Fésüs L; Szondy Z
Hepatology; 2005 Sep; 42(3):578-87. PubMed ID: 16108039
[TBL] [Abstract][Full Text] [Related]
19. Tissue transglutaminase-mediated chemoresistance in cancer cells.
Verma A; Mehta K
Drug Resist Updat; 2007; 10(4-5):144-51. PubMed ID: 17662645
[TBL] [Abstract][Full Text] [Related]
20. Tissue transglutaminase (TG2) facilitates phosphatidylserine exposure and calpain activity in calcium-induced death of erythrocytes.
Sarang Z; Mádi A; Koy C; Varga S; Glocker MO; Ucker DS; Kuchay S; Chishti AH; Melino G; Fésüs L; Szondy Z
Cell Death Differ; 2007 Oct; 14(10):1842-4. PubMed ID: 17612588
[No Abstract] [Full Text] [Related]
[Next] [New Search]